Figure 713

Pretransplant HCV infection effect on outcome. Reports have varied from different centers concerning the impact of pretrans-plantation hepatitis C virus (HCV) infection on outcome after transplantation. Patient survival and graft survival were significantly worse among patients with anti-HCV infection in some studies [99,100]; in other studies a measurable impact could not be detected [90,101]. Some of these differences could be attributed to geographic variation in the prevalence of various HCV genotypes, differing immunosuppressive protocols, and length of follow-up after transplantation.

ELISA—enzyme-linked immunosorbent assay; RIBA—recombinant immunoblot assay. *Numbers in parentheses indicate years after transplatation.

0 0

Post a comment